GLUTEN SCREENING FROM PHARMACEUTICAL PRODUCTS, AN IMPERATIVE FOR CELIAC DISEASE MANAGEMENT.
SIMONA OANCEA1*, MIHAELA STOIA2
1University “Lucian Blaga” of Sibiu, Department of Biochemistry and Toxicology, Str. I. Raţiu 7-9, 550012 Sibiu, Romania
2Authority of Public Health, Sibiu, Str. Gh. Bariţiu 3, Sibiu, Romania
*corresponding author: e-mail: simona.oancea@ulbsibiu.ro
Download Full Article

Abstract:

Celiac disease is a chronic intestinal disorder caused by intolerance to gluten. It is recognized that pharmaceutical products may contain traces of gluten which will cause acute illness in celiac patients. In the present paper we investigated the content of potentially hidden gluten ingredient in basic children drugs using the immunochromatographic visual test. The negative gluten results are relevant to complete the existing lists of gluten-free drugs. The visual assay proved to be an efficient rapid tool for gluten screening as an alternative to the enzyme-linked immunosorbent assay (ELISA) techniques.

Top